Even though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report that …
Read the original:
UBS Picks Large Cap Biotechnology trade stocks online to Outperform the Rest of 2013